摘要
目的 探讨倍他乐克与盐酸地尔硫[艹卓]联用治疗阵发性心房颤动（房颤）的临床疗效。方法 将阵发性房颤患者116例随机分为2组，倍他乐克加盐酸地尔硫[艹卓]联合治疗组60例，普罗帕酮组56例，疗程均为4周。结果 联合治疗组有效率75％，普罗帕酮组有效率64％，二者差异有显著性（P〈0．05）。联合治疗组不良反应率为8．3％；普罗帕酮组为16．1％，与心脏有关的不良反应为7．9％。随访期间未发生严重心脏事件。结论 倍他乐克与盐酸地尔硫[艹卓]联合治疗阵发性房颤疗效优于普罗帕酮。
Objective To explore the clinical therapeutic effect of Betaloc in combination with dihiazem in treating paroxysmal atrial fibrillation （ PAF ）. Methods One hundred and sixteen cases of PAF were randomly divided into two groups ： Betaloc in combination with dihiazem group （ combination gorup, n = 60 ） and propafenone group （ n = 56 ）. The treatment course averaged 4 weeks. Results The response rates were 75% and 64% in combination group and propafenone group, respectivley （ P 〈 0.05 ）. The adverse effects incidence was 8.3% in combination group and 16.1% in propafenone group,which had 7.9% adverse effect related to heart. No severe cardiac event occurred during following up period. Conclusion Betaloc in combination with diltiazem is superior to propafenone in treating PAF.
出处
《中国医药》
2007年第3期147-148,共2页
China Medicine
